Do patients with CKD have increased platelet activation and an attenuated response to dual antiplatelet therapy compared to patients without renal insufficiency?
Chronic kidney disease is associated with increased baseline platelet activation and a blunted response to dual antiplatelet therapy, which may contribute to higher ischemic risks in this population.
Patients with CKD exhibit increased platelet activation, and an attenuated response to dual antiplatelet therapy compared with patients without renal insufficiency.
Gremmel et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: